PART 1 Flashcards
(180 cards)
What is the most common non-reducing sugar
Sucrose
Sucrose does not have an aldehyde or ketone group. Thus,
making it a non-reducing sugar.
Simplest CHO:
Glyceraldehyde
Structural properties of Carbohydrates
- Size of the base carbon chain
- Location of the CO function group
- Number of Sugar Units
- Stereochemistry of the compounds
- Pertains to beta and alpha configuration
- Appearance of carbohydrate
- Fischer or haworth projection *no recall
from boards
All sugars must be digested to this monosaccharide.
Carbohydrates
Serves as major source of energy for the body
Carbohydrates
Sugar that contains 3, 4, 5, 6 carbon atoms (triose, tetroses, pentoses and hexoses, etc.)
Monosaccharide
Glucose is the only monosaccharide used by the body for energy
Carbohydrates
Sugar that cannot be hydrolyzed to a simpler form
Monosaccharide
end product of CHO digestion is:
Glucose
energy mediator of oxidation of glucose is:
ATP (Adenosine Triphosphate)
glucose + glucose:
Maltose; Maltase
Formed by interaction of two monosaccharides; separated by hydrolysis
Disaccharides
glucose + galactose
Lactose; Lactase
glucose + fructose:
Sucrose; Sucrase
What organs produce maltose, lactose, and sucrose
Pancreas
Remedy for constipation
Soluble fibers
<10 - >2 monosaccharides (Soluble fibers)
Oligosaccharides
Linkage of many monosaccharide units ; linked by glycosidic bond
polysaccharides
Include starch (known polysaccharide), glycogen & cellulose
Polysaccharides
What is the immediate product of starch in hydrolysis?
A. Glucose
B. Maltose
C. Sucrose
D. Lactose
B.Maltose. The enzyme responsible is amylase. When the maltose is hydrolyzed by maltase, you will produce two molecules of glucose. Marami nagkakamali dito
because initially they answered glucose instead of maltose.
Final hydrolysis
Small Intestine
Metabolic disease characterized by hyperglycemia resulting from defects in insulin secretion, insulin action or both
DIABETES MELLITUS
In severe DM the ratio of B-hydroxybutyrate to acetoacetate is ___
6.1
Pathogenesis
β-cell destruction
TYPE 1 (IDDM